LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects.

Wageningen University135 enrolled

Overview

Hypertension is an increasingly important medical and public health issue. Literature suggests that there may be a role for dairy foods in the prevention and treatment of hypertension. Recently, it has been suggested that several peptides in milk proteins could have blood pressure lowering properties. LACTOPRES is a randomised, double-blind parallel trial to assess the blood pressure effect of an increased intake of dairy peptides in humans.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

DOUBLE

Enrollment

135

Conditions

Hypertension

Interventions

dairy peptidesBEHAVIORAL

Eligibility

Sex: ALLMin age: 35 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * systolic blood pressure \>= 140 mmHg * BMI between 18 and 32 kg/m2 * apparently healthy Exclusion Criteria: * antihypertensive medication * medically prescribed or slimming diet * lactating, pregnant * irregular pulse

Locations (1)

Wageningen University, Division of Human Nutrition

Wageningen, Netherlands

Outcomes

Primary Outcomes

Blood pressure

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.